CS
GOSS icon

Credit Suisse’s Gossamer Bio GOSS Stock Holding History

Credit Suisse’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-436
Closed -$75.7K – 3453
2022
Q4 		$75.7K Sell
436
-6
-1% -$3.95K ﹤0.01% 3366
2022
Q3 		$423K Buy
442
+4
+0.9% +$3.97K ﹤0.01% 2887
2022
Q2 		$293K Sell
438
-40
-8% -$24.8K ﹤0.01% 3175
2022
Q1 		$332K Sell
478
-20
-4% -$15.4K ﹤0.01% 3176
2021
Q4 		$451K Buy
498
+72
+17% +$68.4K ﹤0.01% 3889
2021
Q3 		$428K Buy
426
+12
+3% +$8.84K ﹤0.01% 3907
2021
Q2 		$268K Sell
414
-90
-18% -$62.4K ﹤0.01% 4161
2021
Q1 		$373K Sell
504
-640
-56% -$516K ﹤0.01% 3921
2020
Q4 		$884K Buy
1,144
+81
+8% +$63.8K ﹤0.01% 3415
2020
Q3 		$1.05M Buy
1,063
+27
+3% +$28.6K ﹤0.01% 2883
2020
Q2 		$1.08M Buy
1,036
+538
+108% +$541K ﹤0.01% 2850
2020
Q1 		$404K Sell
498
-102
-17% -$107K ﹤0.01% 3234
2019
Q4 		$750K Buy
600
+393
+190% +$633K ﹤0.01% 3317
2019
Q3 		$277K Buy
207
+63
+44% +$100K ﹤0.01% 3737
2019
Q2 		$256K Buy
+144
New +$220K ﹤0.01% 3756

Other funds holding GOSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Credit Suisse's GOSS Position: Q1 2023 in Review

Credit Suisse sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 436 shares — an estimated $75.7K sold.

Credit Suisse first reported a position in GOSS in Q2 2019 and held it in 15 quarters. The position peaked at $1.08M in Q2 2020. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • Credit Suisse reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 436 Gossamer Bio shares in Q1 2023, an estimated $75.7K.
  • Credit Suisse first reported a position in Gossamer Bio in Q2 2019 and held it in 15 quarters.
  • Credit Suisse's Gossamer Bio position peaked at $1.08M in Q2 2020.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.